1. Introduction {#sec1-jcm-08-01144}
===============

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection \[[@B1-jcm-08-01144]\]. The incidence of sepsis and septic shock are rising and, despite considerable advances in understanding, morbidity and mortality remain high \[[@B2-jcm-08-01144]\]. Even in high income countries, the mortality rate of hospital-treated sepsis exceeds 20%, reflecting a global burden of more than 5.3 million deaths annually \[[@B3-jcm-08-01144]\]. Community-acquired pneumonia (CAP) is the most common source of sepsis, accounting for over 40% of cases in major studies, and is responsible for disproportionate morbidity and mortality \[[@B4-jcm-08-01144]\]. Early protocolised resuscitation of patients with sepsis is known to improve outcomes \[[@B5-jcm-08-01144],[@B6-jcm-08-01144]\], whilst prognosis is worse in those in whom identification of critical illness is delayed \[[@B7-jcm-08-01144],[@B8-jcm-08-01144],[@B9-jcm-08-01144]\].

Therefore, the early identification of patients with sepsis who are at high risk of deterioration or death is vital to enable appropriate initial management and consideration of escalation to higher level care. Widely used sepsis screening scores, such as the Systemic Inflammatory Response Syndrome (SIRS) criteria and the National Early Warning Score (NEWS), are of limited prognostic utility due to inadequate specificity \[[@B10-jcm-08-01144],[@B11-jcm-08-01144]\]. The recently recommended quick Sequential Organ Failure Assessment (qSOFA) score \[[@B1-jcm-08-01144]\] is intended to be used as a severity assessment tool but fails to identify half of patients with sepsis who will subsequently die \[[@B10-jcm-08-01144],[@B11-jcm-08-01144],[@B12-jcm-08-01144]\]. The calculation of these scores requires training and can be relatively time consuming.

The shock index (SI), derived using two simple physiological measures, heart rate divided by systolic blood pressure, is a simple bedside assessment of cardiovascular status which has been used to predict adverse outcomes in patients with haemorrhagic shock \[[@B13-jcm-08-01144],[@B14-jcm-08-01144]\] and pulmonary embolism \[[@B15-jcm-08-01144]\]. The normal range is 0.5--0.7 \[[@B16-jcm-08-01144]\]. Various modifications of the shock index have been proposed to improve accuracy, including the Adjusted Shock Index (ASI; SI adjusted for body temperature) \[[@B17-jcm-08-01144]\] and the Modified Shock Index (MSI; heart rate/mean arterial pressure) \[[@B18-jcm-08-01144]\]. These have been applied to patients with CAP, and existing CAP severity scores modified to incorporate shock index \[[@B16-jcm-08-01144],[@B17-jcm-08-01144],[@B19-jcm-08-01144],[@B20-jcm-08-01144],[@B21-jcm-08-01144]\]. The usefulness of shock index or its modifications for predicting outcomes in sepsis and CAP has been previously investigated, but no systematic review has synthesised the evidence to determine the prognostic utility of shock index in sepsis and CAP.

The aim of this systematic review was therefore to examine the current evidence-base and determine whether shock index or its modifications are useful predictors of morbidity and mortality in hospitalised adult patients with: (i) suspected sepsis; or (ii) community-acquired pneumonia.

2. Materials and Methods {#sec2-jcm-08-01144}
========================

The systematic review and meta-analysis were undertaken in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendations. The protocol was registered through the PROSPERO database (registration number: CRD42018096473).

2.1. Selection Criteria {#sec2dot1-jcm-08-01144}
-----------------------

The eligibility criteria are presented below:

Inclusion: (i) Study participants comprise adult (≥18 years) patients who were hospitalised with a diagnosis of sepsis or CAP. (ii) Measurements reported include shock index, adjusted shock index or modified shock index. (iii) Outcome measures reported include mortality, requirement for Intensive Care admission, requirement for vasoactive support, renal replacement therapy or mechanical ventilation. (iv) Prospective or retrospective cohort study design.

Exclusion: Lack of available full-text report.

2.2. Search Strategy {#sec2dot2-jcm-08-01144}
--------------------

The databases MEDLINE, EMBASE, Allie and Complementary Medicine Database (AMED), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Open Grey, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform (WHO ITRP) were searched from their inception to 21st November 2016. This was updated on 26th March 2019. The search strategy is presented in [Table S1](#app1-jcm-08-01144){ref-type="app"}. A hand search of the reference list of all relevant reviews and primary articles was performed to identify any articles not captured by the electronic searches. Restrictions were not applied, such as age of publication, language or number of included patients. Only full-text reports were considered. For relevant conference abstracts meeting eligibility criteria, authors were contacted to determine the existence of any related full-text report.

2.3. Study Selection {#sec2dot3-jcm-08-01144}
--------------------

All search results were independently screened by a minimum of two reviewers (DM, RB, MN). The full texts of those considered potentially eligible were obtained and reviewed against eligibility criteria by the same individuals. Any disagreement on study eligibility was resolved through discussion with senior review team members (TOS, PKM).

2.4. Data Extraction {#sec2dot4-jcm-08-01144}
--------------------

All data were independently extracted by two reviewers (DM, RB) using a piloted data extraction template, with disagreements resolved by discussion. Data were extracted for all studies included the following: year of publication, study design, setting, inclusion/exclusion criteria, sample size, age and sex of participants, source of sepsis, measurement of interest, threshold values for binary classification of cohort, outcome measures used, percentage mortality of cohort, test characteristics for prediction of outcomes of interest (where data allowed).

2.5. Quality Assessment {#sec2dot5-jcm-08-01144}
-----------------------

Risk of bias and study quality was assessed using the Downs and Black tool for non-randomised controlled trials \[[@B22-jcm-08-01144]\], which was applied to eligible studies by two independent reviewers (DM, RB). Disagreements were resolved through discussion. Questions 8, 14, 19, 23 and 24 of the Downs and Black tool are not relevant to cohort studies, so were omitted.

2.6. Data Analysis {#sec2dot6-jcm-08-01144}
------------------

Study heterogeneity was determined by visual inspection of the data extraction table by two reviewers (DM, RB), assessing for between-study variability/similarity, study design, participant characteristics, reported measurements and outcomes. This identified substantial inter-study heterogeneity for all outcomes. Consequently, data were analysed using a narrative approach.

3. Results {#sec3-jcm-08-01144}
==========

3.1. Search Results {#sec3dot1-jcm-08-01144}
-------------------

The PRISMA flow diagram summarising the search results is presented as [Figure 1](#jcm-08-01144-f001){ref-type="fig"}. A total of 754 citations were identified. From these, 50 were potentially eligible. Based on a full-text review of these studies, 15 satisfied the pre-defined eligibility criteria and were included.

3.2. Quality Assessment {#sec3dot2-jcm-08-01144}
-----------------------

A summary of the Downs and Black \[[@B22-jcm-08-01144]\] quality assessment is presented in [Table S2](#app1-jcm-08-01144){ref-type="app"}. There was marked variability in the quality of the evidence. Papers frequently successfully reported the study objectives (100%), measurements of interest (100%), main outcome measures (93%), population characteristics (87%) and probability values of their inferential analysis (93%). However, papers' main findings were less well described (60%), and few recorded (33%) or adjusted for potential confounders (27%). External validity of the evidence was generally low, with few studies conducted in large diverse populations (20%). Risk of bias in the evidence was low with the vast majority studies recruiting all patients from the same population at the same time point (93%), and with outcomes assessed at a standardised time-point (87%). Sixty percent of studies reported a sample size calculation.

3.3. Characteristics of Studies Included {#sec3dot3-jcm-08-01144}
----------------------------------------

A summary of the characteristics of included studies is presented in [Table 1](#jcm-08-01144-t001){ref-type="table"}.

### 3.3.1. Sepsis {#sec3dot3dot1-jcm-08-01144}

Nine studies (*n* = 7759) investigated patients with sepsis. Of these, seven were retrospective and eight were of single-centre design. Seven assessed an Emergency Department (ED) population, with remaining studies using pre-hospital \[[@B23-jcm-08-01144]\] and medical ICU \[[@B24-jcm-08-01144]\] cohorts. There was marked inter-study heterogeneity in criteria used to identify cohorts and in disease severity, with reported mortality rates ranging from 5 to 54%. Seven studies included patients with sepsis of any source, whilst one investigated a specific cohort of elderly patients with influenza \[[@B25-jcm-08-01144]\], and another only included patients with septic incomplete miscarriage \[[@B26-jcm-08-01144]\].

Eight studies (*n* = 7181) assessed the prognostic utility of shock index, though there was considerable variation in the threshold values used, ranging from ≥ 0.7 to ≥ 1.0. Five of these studies measured shock index for a single time point (on admission) and others considered serial ED measurements \[[@B27-jcm-08-01144]\] or two interval measurements \[[@B26-jcm-08-01144],[@B28-jcm-08-01144]\]. Outcomes of interest included mortality (100%), intensive care admission (11%) \[[@B23-jcm-08-01144]\] and requirement for vasoactive support (11%) \[[@B27-jcm-08-01144]\].

### 3.3.2. Community-Acquired Pneumonia {#sec3dot3dot2-jcm-08-01144}

Six studies (*n* = 938) investigated patients with CAP. Notably, three of these studies (by one of the co-authors of this work) utilised the same population of 190 patients, variously applying SI and ASI \[[@B29-jcm-08-01144]\], the CURSI and CURASI scores (modifications of the CURB-65 score where the blood pressure element replaced by SI or ASI and age is omitted) \[[@B30-jcm-08-01144]\] or the CARSI and CARASI scores (modifications of the CURB65 score where the blood pressure element is replaced by SI or ASI and urea is omitted) \[[@B17-jcm-08-01144]\] to patients with CAP. Two further studies \[[@B19-jcm-08-01144],[@B21-jcm-08-01144]\] assessed the prognostic utility of CURSI and CURASI, whilst one \[[@B20-jcm-08-01144]\] compared the SIPF score (comprising SI and PaO2/FiO2 ratio) to CURB-65 and the Pneumonia Severity Index (PSI). The diagnostic criteria for CAP were homogenous across studies but there was variation in disease severity, with rates of mortality ranging from 8 to 28%.

3.4. Shock Index in Patients with Sepsis {#sec3dot4-jcm-08-01144}
----------------------------------------

### 3.4.1. Shock Index as a Predictor of Mortality in Patients with Sepsis {#sec3dot4dot1-jcm-08-01144}

Results are shown in [Table 2](#jcm-08-01144-t002){ref-type="table"}. In four of five adequately powered studies \[[@B25-jcm-08-01144],[@B31-jcm-08-01144],[@B32-jcm-08-01144],[@B33-jcm-08-01144]\] where shock index was measured at the time of ED admission, there was a positive correlation between elevated shock index and mortality. The largest studies, both including ED patients who had blood cultures taken, reported odds ratios for mortality of 2.0 (1.8--2.9) \[[@B31-jcm-08-01144]\] and 3.0 (1.8--4.2) \[[@B33-jcm-08-01144]\] using a threshold of SI ≥ 1.0. Other studies reported that serial measurements of shock index \[[@B27-jcm-08-01144]\] or two interval measurements \[[@B26-jcm-08-01144],[@B28-jcm-08-01144]\] allowed more accurate mortality prediction than a single measurement, though some of these studies were methodologically poor. Only one study \[[@B31-jcm-08-01144]\] reported outcomes for shock index using two different threshold values (≥ 0.7 and ≥ 1.0) with the higher cut-off predictably increasing specificity at the expense of sensitivity. Jamies et al. \[[@B32-jcm-08-01144]\] did not report specific outcome data for shock index, but included SI ≥ 1.5 in a multivariate model that predicted 28-day mortality with moderate accuracy (AUROC 0.75) in a population of ED patients.

### 3.4.2. Shock Index as a Predictor of Morbidity in Sepsis {#sec3dot4dot2-jcm-08-01144}

Two studies investigated the use of shock index as a predictor of morbidity in sepsis. Both reported an association between elevated shock index and increased morbidity, with one \[[@B23-jcm-08-01144]\] finding that a pre-hospital shock index ≥ 0.7 was a strong predictor of ICU admission (OR 5.96; 95% CI1: 49--25.78). Wira et al. \[[@B27-jcm-08-01144]\] reported that sustained shock index elevation (≥ 0.8 for \> 80% of ED measurements) was a predictor of vasopressor dependence within 72 h of admission, compared to patients with non-sustained elevation in shock index (OR 4.42; 95% CI: 2.28--8.55). No studies reported on the association between shock index and requirement for renal replacement therapy or mechanical ventilation.

### 3.4.3. Modifications of Shock Index in Patients with Sepsis {#sec3dot4dot3-jcm-08-01144}

One study reported a weak association between a sustained but not isolated elevation in modified shock index ≥ 1.3 in medical ICU patients during the first 6 h of admission (OR 1.13; 95% CI: 1.02--1.26) \[[@B24-jcm-08-01144]\].

3.5. Shock Index in Patients with CAP {#sec3dot5-jcm-08-01144}
-------------------------------------

### 3.5.1. Shock Index and Adjusted Shock Index as a Predictor of Mortality and Morbidity in Patients with CAP {#sec3dot5dot1-jcm-08-01144}

Two studies reported on the prognostic utility of shock index for mortality in patients with CAP \[[@B21-jcm-08-01144],[@B29-jcm-08-01144]\]. SI ≥ 1 predicted mortality with a low sensitivity and relatively high specificity, similar to its performance in the patients with undifferentiated sepsis ([Table 3](#jcm-08-01144-t003){ref-type="table"}). ASI ≥ 1.0 did not perform significantly better in the only cohort that reported relevant data \[[@B29-jcm-08-01144]\], though the study may not have been sufficiently powered to show this. No studies reported on the association between shock index or adjusted shock index and morbidity in patients with CAP.

### 3.5.2. Modifications of Shock Index and Adjusted Shock Index in Patients with CAP {#sec3dot5dot2-jcm-08-01144}

Three studies reported on the performance of the CURSI score for predicting mortality in patients with CAP ([Table S3](#app1-jcm-08-01144){ref-type="app"}) \[[@B19-jcm-08-01144],[@B21-jcm-08-01144],[@B30-jcm-08-01144]\]. The CURSI score did not outperform CURB65 in any study, and in the largest cohort \[[@B21-jcm-08-01144]\] its sensitivity was inferior to that of CURB65. In two studies \[[@B19-jcm-08-01144],[@B30-jcm-08-01144]\], the CURSI and CURASI scores performed equivalently. Using the same patients population as Myint et al. \[[@B30-jcm-08-01144]\], Musonda et al. \[[@B17-jcm-08-01144]\] found that the CARSI and CARASI scores performed equivalently with CURB65, although with a non-significant trend towards lower sensitivity. One poor quality study \[[@B20-jcm-08-01144]\] reported that the SPIF score performed equivalently to CURB65 and the Pneumonia Severity Index for prediction of mortality or ICU admission in patients with CAP.

4. Discussion {#sec4-jcm-08-01144}
=============

The early assessment of disease severity is vital in patients with suspected sepsis and CAP, due to the high rate of mortality associated with these conditions, and the potential modifiability of the disease process and outcome \[[@B5-jcm-08-01144],[@B6-jcm-08-01144]\]. The early identification of patients at high risk of mortality enables the appropriate allocation of scarce recourses, such as intensive care beds. The findings of this review suggest that initial elevated shock index is a moderately accurate predictor of mortality in adult patients with suspected sepsis. The two large studies found a similar effect size, reporting mortality odds ratios of 2.24 (1.81--2.91) \[[@B31-jcm-08-01144]\] and 2.80 (1.80--4.20) \[[@B33-jcm-08-01144]\] using a threshold of SI ≥ 1.0. Whilst smaller studies \[[@B23-jcm-08-01144],[@B26-jcm-08-01144],[@B27-jcm-08-01144]\] did not detect a significant association between initial shock index and mortality, they are at high risk of type 2 error. Elevated initial shock index was more strongly predictive of mortality in a cohort of elderly Taiwanese patients with influenza and a low case mortality rate \[[@B25-jcm-08-01144]\], though the generalisability of this study is low given the highly specific population investigated. In patients with CAP, the most common cause of sepsis, elevated shock index appears to predict mortality with similar accuracy to that seen in patients with sepsis \[[@B21-jcm-08-01144],[@B29-jcm-08-01144]\].

There was broad agreement across studies that SI ≥ 1.0 has low sensitivity and relatively high specificity for mortality prediction, suggesting that it may be useful as a "rule in" test when positive to trigger prompt escalation of care, whilst a negative result should not be considered reassuring. However, it is unclear whether there is a practical application for shock index in sepsis prognostication given that NEWS, SIRS and qSOFA are all likely to have superior sensitivity \[[@B11-jcm-08-01144],[@B12-jcm-08-01144]\], and qSOFA has a comparable specificity \[[@B12-jcm-08-01144]\]. Shock Index may identify some high-risk patients missed by qSOFA, as this score integrates fewer haemodynamic variables than the others (blood pressure only).

There was weak evidence that sustained elevation of SI following initial resuscitation may be more predictive of adverse outcomes \[[@B26-jcm-08-01144],[@B27-jcm-08-01144],[@B28-jcm-08-01144]\], though this requires validation in methodologically rigorous and adequately powered studies. Furthermore, the requirement for periodic measurement of SI may not be practical in the ED where resource is limited and early decision making on patient disposition is vital to enable prompt transfer.

Modified shock index is thought to be more accurately predictive of mortality than shock index in undifferentiated Emergency Department patients \[[@B18-jcm-08-01144]\], but it has only been assessed in sepsis patients in ICU, where sustained elevation was weakly predictive of mortality \[[@B24-jcm-08-01144]\]. The prognostic utility of adjusted shock index has only been reported in one study in patients with CAP \[[@B29-jcm-08-01144]\], where it performed equivalently with SI for prediction of mortality. The assessment of these indices in larger populations of sepsis patients is required. Attempts to integrate SI and ASI into more complex clinical severity scores for CAP \[[@B20-jcm-08-01144],[@B21-jcm-08-01144],[@B30-jcm-08-01144]\] has not yet demonstrated convincing benefits over the CURB-65 score, though the CARSI score may offer an equivalent performance without the requirement for urea testing \[[@B17-jcm-08-01144]\], and thus can be useful in primary care setting to assess CAP severity.

In studies that adjusted for covariates (e.g., age, sex, physiological observations \[[@B29-jcm-08-01144],[@B32-jcm-08-01144],[@B33-jcm-08-01144]\]), shock index was consistently found to be an independent predictor of mortality. This is also seen in conditions as diverse as stroke \[[@B16-jcm-08-01144]\], myocardial infarction \[[@B34-jcm-08-01144]\], pulmonary embolism \[[@B15-jcm-08-01144]\], and haemorrhagic shock \[[@B13-jcm-08-01144],[@B14-jcm-08-01144]\], highlighting the common importance of haemodynamic instability as an antecedent mortality. Unselected patients who present to hospital with overt shock (with hypotension) have a much higher mortality than those who present with covert shock (without hypotension) \[[@B35-jcm-08-01144]\]. The value of SI lies in its ability to identify the cohort of patients with covert shock at an earlier stage in their disease process, prior to the failure of their innate compensatory mechanisms, thus maximising the opportunity for meaningful intervention.

The strengths of this systematic review include conducting the comprehensive literature search utilising several databases, and the duplication of literature screening, selection and data extraction by two reviewers to ensure accuracy. Notable limitations include the predominantly retrospective evidence base, and marked heterogeneity in study populations, index measurements and reporting of outcomes. This precluded a meaningful estimation of pooled effects size by meta-analysis, or assessment for publication bias by funnel plot. The variability of study populations and mortality rate, and the relative lack of multi-centre studies may limit the generalisability of our findings. There was also little or no data for some of the pre-specified morbidity outcomes, and there was insufficient data to draw conclusions on the utility of ASI and MSI in our populations of interest.

5. Conclusions {#sec5-jcm-08-01144}
==============

In conclusion, shock index is a moderately accurate predictor of mortality in adult patients with sepsis and CAP, which may have utility as a "rule-in" tool to identify high-risk patients. The simplicity and rapidity with which it can be calculated is an advantage over existing sepsis scoring systems, particularly in resource-limited settings. Combining shock index with other established and rapidly available predictors of prognosis, such as lactate and neutrophil/lymphocyte ratio, may further improve prognostic accuracy. Future research should focus on: (i) whether the integration of SI into current decision-making tools for sepsis or CAP can augment their accuracy; and (ii) the use of the electronic recoding of vital signs to determine whether trends in shock index better predict outcomes than one-off measurements.

The following are available online at <https://www.mdpi.com/2077-0383/8/8/1144/s1>, Table S1: Medline search strategy, Table S2: Downs and Black quality assessment for included studies, Table S3: CURASI score as a predictor of mortality in CAP.
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jcm-08-01144-t001_Table 1

###### 

Characteristic of included studies.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                           Design                 *n*    Location                   Setting          Study Population                                                                            Mortality (%)   Admitted to ICU (%)   Index Test and Range                               Outcome(s) of Interest
  ----------------------------------------------------- ---------------------- ------ -------------------------- ---------------- ------------------------------------------------------------------------------------------- --------------- --------------------- -------------------------------------------------- -----------------------------------------------------
  **Sepsis studies**                                                                                                                                                                                                                                                                                                   

  **Baez et al., 2013 \[[@B23-jcm-08-01144]\]**         Retrospective cohort   63     USA;\                      Pre-hospital     Adults (≥ 18) with ICD-9 diagnostic code of sepsis, severe sepsis or septic shock           34.9            68.3                  SI ≥ 0.7                                           In-hospital mortality ICU admission
                                                                                      1 centre                                                                                                                                                                                                                         

  **Berger et al., 2013 \[[@B31-jcm-08-01144]\]**       Retrospective cohort   2524   USA;\                      ED               Adults (≥ 21) screened for sepsis using standardised blood order                            13.5            \-                    SI ≥ 0.7; SI ≥ 1                                   28-day mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Chung et al., 2019 \[[@B25-jcm-08-01144]\]**        Retrospective cohort   409    Taiwan;\                   ED               Elderly patients (≥ 65) with pyrexia confirmed influenza                                    4.9             \-                    SI ≥ 1.0                                           30-day mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Jaimes et al., 2005 \[[@B32-jcm-08-01144]\]**       Prospective cohort     533    Colombia;\                 ED               Adults (≥ 16) suspected sepsis (2012 definition)                                            18.9            14.1                  SI; full range                                     Multivariable modelling to predict 28-day mortality
                                                                                      2 centres                                                                                                                                                                                                                        

  **Jayarakash et al., 2018 \[[@B24-jcm-08-01144]\]**   Retrospective cohort   578    USA;\                      Medical ICU      Adults (≥ 18) admitted to ICU with severe sepsis or septic shock (2012 definition)          19.9            100                   MSI ≥ 1.3                                          In-hospital mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Lombaard et al., 2015 \[[@B26-jcm-08-01144]\]**     Audit                  47     South Africa;\             Maternity ward   Adult patients with septic incomplete abortion                                              19.2            \-                    SI ≥ 1.0                                           In-hospital mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Talmor et al., 2007 \[[@B33-jcm-08-01144]\]**       Prospective cohort     3260   Israel;\                   ED               Adults (≥ 18) who had blood cultures taken                                                  4.7             12                    SI ≥ 1.0                                           In-hospital mortality or ICU
                                                                                      1 centre                                                                                                                                                                                                                         

  **Wira et al., 2014 \[[@B27-jcm-08-01144]\]**         Retrospective cohort   295    USA;\                      ED               Adults (≥ 18) with severe sepsis (2012 definition)                                          15.6            \-                    SI ≥ 0.8 for ≥ 80% of ED values                    Vasopressor dependence by 72-h 28-day mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Yussof et al., 2012 \[[@B28-jcm-08-01144]\]**       Retrospective cohort   50     Malaysia;\                 ED               Adults (≥ 18) triaged to resuscitation area with sepsis or septic shock (2012 definition)   54%             \-                    SI; entire range at presentation and 2 h           In-hospital mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Community-acquired pneumonia (CAP) studies**                                                                                                                                                                                                                                                                       

  **Curtain et al., 2013 \[[@B19-jcm-08-01144]\]**      Prospective cohort     95     UK;\                       Hospital ward    Adults (≥ 18) admitted with CAP (symptoms and new CXR shadow)                               8.4%            9.5%                  SI and ASI ≥ 1.0, as part of CURSI, CURASI score   6-week mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Eldaboosy et al., 2015 \[[@B20-jcm-08-01144]\]**    Retrospective cohort   100    Egypt and Saudi Arabia;\   Hospital ward    Adults admitted with CAP (symptoms and new CXR shadow)                                      9%              34%                   SI ≥ 0.7, as part of SIPF score                    In-hospital mortality ICU admission
                                                                                      2 centres                                                                                                                                                                                                                        

  **Musonda et al., 2011 \[[@B17-jcm-08-01144]\]**      Prospective cohort     190    UK;\                       AMAU             Adults (≥ 18) admitted with CAP (symptoms and new CXR shadow)                               28.4%           \-                    SI ≥ 1.0, as part of CARSI and CARASI score        42-day mortality
                                                                                      3 centres                                                                                                                                                                                                                        

  **Myint et al., 2010 \[[@B30-jcm-08-01144]\]**        Prospective cohort     190    UK;\                       AMAU             Adults (≥ 18) admitted with CAP (symptoms and new CXR shadow)                               28.4%           \-                    SI ≥ 1.0, as part of CURSI and CURASI score        42-day mortality
                                                                                      3 centres                                                                                                                                                                                                                        

  **Nullmann et al., 2014 \[[@B21-jcm-08-01144]\]**     Retrospective cohort   553    Germany;\                  Hospital ward    Adults (≥ 18) admitted with CAP (symptoms and new CXR shadow)                               10.7%           10.5%                 SI ≥ 1.0, as part of CURSI score                   30-day mortality
                                                                                      1 centre                                                                                                                                                                                                                         

  **Sankaran 2011 \[[@B29-jcm-08-01144]\]**             Prospective cohort     190    UK;\                       AMAU             Adults (≥ 18) admitted with CAP (symptoms and new CXR shadow)                               28.4%           \-                    SI ≥ 1.0\                                          42-day mortality
                                                                                      3 centres                                                                                                                                                                     ASI ≥ 1.0                                          
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

jcm-08-01144-t002_Table 2

###### 

Association between SI and mortality in patients with sepsis.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                         *n*               SI Threshold                             Mortality (%)   Test Characteristics for Prediction of Mortality                                                 
  --------------------------------------------------- ----------------- ---------------------------------------- --------------- -------------------------------------------------- -------------- -------------- --------------- ---------------
  **Baez et al., 2013 \[[@B23-jcm-08-01144]\]**       63                SI ≥ 0.7                                 34.9            \-                                                 \-             \-             \-              1.66\
                                                                                                                                                                                                                                  (0.59--4.65)

  **Berger et al., 2013 \[[@B31-jcm-08-01144]\]**     2524              SI ≥ 0.7                                 13.5            0.71\                                              0.41\          0.17\          0.89\           1.68\
                                                                                                                                 (0.66--0.76)                                       (0.39--0.43)   (0.16--0.18)   (0.88--0.91)    (1.32--2.14)

  \-                                                  SI ≥ 1.0          \-                                       0.32\           0.79\                                              0.23\          0.85\          2.24\           
                                                                                                                 (0.27--0.36)    (0.77--0.81)                                       (0.20--0.26)   (0.84--0.86)   (1.81--2.91))   

  **Chung et al., 2019 \[[@B25-jcm-08-01144]\]**      409               SI ≥ 1.0                                 4.9             0.30\                                              0.94\          0.21\          0.96\           6.78\
                                                                                                                                 (0.12--0.54)                                       (0.91--0.96)   (0.11--0.36)   (0.95--0.97)    (2.39--19.29)

  **Lombbard et al., 2015 \[[@B26-jcm-08-01144]\]**   47                SI ≥ 1.0                                 19.2            0.77\                                              0.29\          0.21\          0.85\           1.43\
                                                                                                                                 (0.40--0.97)                                       (0.15--0.46)   (0.15--0.28)   (0.25--0.54)    (0.26--7.97)

  **Talmor et al., 2007 \[[@B33-jcm-08-01144]\]**     3260              SI ≥ 1.0                                 4.7             \-                                                 \-             \-             \-              2.8\
                                                                                                                                                                                                                                  (1.8--4.2)

  **Wira et al., 2014 \[[@B27-jcm-08-01144]\]**       295               SI ≥ 0.8 for \> 80% of ED measurements   15.6            0.59\                                              0.55\          0.19\          0.88\           1.71\
                                                                                                                                 (0.43--0.73)                                       (0.48--0.61)   (0.15--0.24)   (0.83--0.91)    (0.90--3.23)

  **Yussof et al., 2012 \[[@B28-jcm-08-01144]\]**     50                SI ≥ 1.2 on admission                    54              0.73                                               0.45           \-             \-              \-

  \-                                                  SI ≥ 1.0 at 2 h   \-                                       0.81            0.79                                               \-             \-             \-              
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

jcm-08-01144-t003_Table 3

###### 

Association between SI/ASI and mortality in patients with CAP.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                         *n*         SI Threshold   Mortality (%)   Test Characteristics for Prediction of Mortality                                                
  --------------------------------------------------- ----------- -------------- --------------- -------------------------------------------------- -------------- -------------- -------------- --------------
  **Nullmann et al., 2014 \[[@B21-jcm-08-01144]\]**   **443**     **SI ≥ 1.0**   10.7            0.25\                                              0.87\          0.18\          0.92\          2.72\
                                                                                                 (0.15--0.38)                                       (0.84--0.90)   (0.12--0.26)   (0.90--0.92)   (1.42--5.21)

  **Sankaran 2011 \[[@B29-jcm-08-01144]\]**           190         SI ≥ 1.0       28.4            0.28\                                              0.83\          0.39\          0.74\          1.89\
                                                                                                 (0.16--0.41)                                       (0.75--0.89)   (0.27--0.54)   (0.71--0.78)   (0.90--3.98)

  \-                                                  ASI ≥ 1.0   \-             0.22\           0.90\                                              0.45\          0.74\          2.49\          
                                                                                 (0.12--0.36)    (0.83--0.94)                                       (0.30--0.63)   (0.71--0.77)   (1.07--5.81)   
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
